Milton Morris

Milton M. Morris, Ph.D.
President and CEO

Milton M. Morris joined NeuSpera™ Medical as its President and CEO in July of 2015. Prior to taking on this role, Milton was a consultant with NeuSpera™ helping to formulate the company’s strategy, establish and drive its programs and launch its formal fundraising activity. During his time as a consultant, Milton became an investor in NeuSpera™ and a Director on its Board.

Prior to consulting for NeuSpera™, Milton was the Sr. Vice President of Research & Development and Emerging Therapies at Cyberonics. Dr. Morris joined Cyberonics as Vice President, Research & Development in January 2009. During his tenure with Cyberonics, the R&D organization has seen significant growth, hiring top medical device talent with relevant skills in ASIC development, neurophysiology/epilepsy, algorithm development, signal processing, alternative powering, RF communication and development of class III active implantable medical devices. Dr. Morris joined Cyberonics from InnerPulse Corporation, a privately held cardiology-focused medical technology start-up company in the Research Triangle Park of North Carolina, where he served as Director, Program Management and Operations. Prior to InnerPulse, Dr. Morris was employed by Guidant Corporation and its successor, Boston Scientific Corporation. During his tenure, he held several positions, including Principal Research Scientist; Director, Research & Development; and Director, Marketing where he served as the Arrhythmia Franchise leader with responsibilities for both the implantable pacemaker and defibrillator businesses for the Cardiac Rhythm Management division of Boston Scientific. Prior to joining Guidant, Dr. Morris spent 5 years working as a Research Assistant in the Medical Computing Laboratory at the University of Michigan in collaboration with the electrophysiology group at the University of Michigan hospital and the Michigan Heart and Vascular Institute. During this period, Dr. Morris was awarded fellowships from the National Science Foundation (NSF) and the National Institutes of Health (NIH) in support of his research on the development of novel approaches to low power arrhythmia classification algorithms designed for implantable defibrillators. Dr. Morris is named as an inventor on 27 patents and an author on 20 peer reviewed publications, book chapters, abstracts and scientific presentations.

Dr. Morris has served as an Adjunct Assistant Professor in the Electrical and Computer Engineering department at the University of Minnesota where he taught Control Systems and served on thesis committees and has been a member of the Northwestern University Robert R. McCormick School of Engineering Advisory Board (present), the University of Michigan Rackham Dean’s Advisory Board (past), the University of Houston Biomedical Engineering Industrial Advisory Board (present), and the Advisory Board for the Weldon School of Biomedical Engineering at Purdue (present). Dr. Morris holds a Masters in Business Administration from the Kellogg School of Management, a Masters and Ph.D. in Electrical Engineering from the University of Michigan and a Bachelor of Science in Electrical Engineering from Northwestern University.

Dr. Morris holds a Masters in Business Administration from Kellogg School of Management, a Masters and Ph.D.in Electrical Engineering from the University of Michigan and a Bachelor of Science in Electrical Engineering from Northwestern University.

Milton has been an active mentor of at risk youth. He and his wife Renee have 4 kids and are members of Windsor Village United Methodist Church in Houston Texas.